227 results
8-K
EX-99.1
ACET
Adicet Bio Inc
10 May 24
Regulation FD Disclosure
6:09am
benchmarks Adicet Bio internal data
ADI-270 contributed CAR-dependent and CAR-independent mechanisms of tumor targeting CD70+/- tumor mixture model Increased
DEFR14A
ACET
Adicet Bio Inc
26 Apr 24
Revised proxy
4:13pm
the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and
8.To transact any … AS ADICET BIO’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024
CORPORATE GOVERNANCE
EXECUTIVE COMPENSATION
DEFA14A
ACET
Adicet Bio Inc
23 Apr 24
Additional proxy soliciting materials
5:05pm
independent registered public accounting firm for the fiscal year ending December 31, 2024. For NOTE: Such other business as may properly come before
PRE 14A
e500 uhz8vsmins91
12 Apr 24
Preliminary proxy
5:23pm
8-K
EX-1.1
btptxqx
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-5.1
a1hky6u4
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
424B5
1k2byqlgl0lo7p d2k
22 Mar 24
Prospectus supplement for primary offering
4:12pm
S-8 POS
EX-23.1
9vhl1inve9ul z5hqm
19 Mar 24
Registration of securities for employees (post-effective amendment)
4:24pm
S-8 POS
s4xf0z15ygb948xtw
19 Mar 24
Registration of securities for employees (post-effective amendment)
4:24pm
S-8 POS
EX-5.1
3jwilcn0m
19 Mar 24
Registration of securities for employees (post-effective amendment)
4:24pm
S-8
EX-23.1
hw7amomyj2cw5yklnb6y
19 Mar 24
Registration of securities for employees
4:20pm
S-8
EX-5.1
tuven
19 Mar 24
Registration of securities for employees
4:20pm
S-8
jytkglbrf
19 Mar 24
Registration of securities for employees
4:20pm
8-K
EX-5.1
e3w0ww7a709y
24 Jan 24
Adicet Bio, Inc. Announces Proposed Public Offering
4:34pm